Established · publishing since 1995Rising activity
HER2/EGFR in Cancer ResearchCancer Cells and MetastasisAdvanced Breast Cancer TherapiesCancer Treatment and PharmacologyBreast Cancer Treatment Studies
Publications
51
Citations
436
Est. group size
—
Recurring co-author estimate
Active years
32
Publishing since 1995
In context
Among 4,953 established Medicine PIs within our index
Citations: 436p25 789 · p75 7,423 · cohort median 2,544
Publications / year (recent): 7.4p25 2 · p75 10.6 · cohort median 4.8
Typically publishes in teams of ~23 · 2% small-team papers (≤3 authors) · across 11 venues
Publication cadence
Publications per year over the last 10 years — averaging 7.4/year recently
Collaborators per year
Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
Recent publications
- Traumatic Unilateral Peripheral Arteriolar Occlusions
JAMA Ophthalmology · 2026
- Figure 3 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2025
- Table 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2025
- Figure 2 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2025
- Table 2 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2025
- Figure 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2025
- The Labor Market and Health Impacts of Reducing Cesarean Section Deliveries
National Bureau of Economic Research · 2025
- The Labor Market and Health Impacts of Reducing Cesarean Section Deliveries
SSRN Electronic Journal · 2025
- Data from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2023
- Supplementary Data from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2023
- Supplementary Figure from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2023
- Supplementary Figure from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2023
- Supplementary Figure from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2023
- Supplementary Figure from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2023
- Supplementary Figure from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
2023
Publishes in
- SSRN Electronic Journal×3
- National Bureau of Economic Research×2
- American Journal of Ophthalmology×1
- BMJ Open×1
- Research Involvement and Engagement×1
Similar researchers
By research-topic overlap
- Erin Macrae
Medicine · The Ohio State University
- Carson Kenum
Medicine · University of Michigan
- Michele Dziubinski
Medicine · University of Michigan
- Kathleen C. Day
Medicine · University of Michigan
- Keith Miller
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile